Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)
This study has been completed.
Sponsor:
Neurocrine Biosciences
Collaborator:
Immune Tolerance Network (ITN)
Information provided by:
Neurocrine Biosciences
ClinicalTrials.gov Identifier:
NCT00079495
First received: March 8, 2004
Last updated: March 20, 2008
Last verified: September 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | April 2005 |
| Estimated Primary Completion Date: | No date given |